{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:59:52Z","timestamp":1770749992522,"version":"3.50.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["0012017"],"award-info":[{"award-number":["0012017"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/150.042\/2023"],"award-info":[{"award-number":["E-26\/150.042\/2023"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["304763\/2021-7"],"award-info":[{"award-number":["304763\/2021-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbagen.2026.130913","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:54:50Z","timestamp":1769702090000},"page":"130913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ectonucleotidases: Possible roles in the tumor microenvironment and influence on tumor progression in breast cancer"],"prefix":"10.1016","volume":"1870","author":[{"given":"Tha\u00eds Cristino","family":"Rocha-Vieira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Roberto","family":"Meyer-Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2026.130913_bb0005","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2026.130913_bb0010","series-title":"Global Cancer Observatory: Cancer Today","year":"2020"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0015","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036905","article-title":"Breast cancer: a review of risk factors and diagnosis","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbagen.2026.130913_bb0020","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ijc.20315","article-title":"Body size and breast cancer risk: findings from the European prospective investigation into Cancer and nutrition (EPIC)","volume":"111","author":"Lahmann","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagen.2026.130913_bb0025","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014viewpoint of the IARC working group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2026.130913_bb0030","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/ijc.27913","article-title":"Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study","volume":"132","author":"Ritte","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagen.2026.130913_bb0035","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/aje\/152.10.950","article-title":"Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the nurses\u2019 health study","volume":"152","author":"Colditz","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbagen.2026.130913_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.epirev.a036115","article-title":"Reproductive factors and breast cancer","volume":"15","author":"Kelsey","year":"1993","journal-title":"Epidemiol. Rev."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","article-title":"Molecular classification of breast cancer","volume":"27","author":"Tsang","year":"2020","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.bbagen.2026.130913_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130913_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr2889","article-title":"Choosing the right cell line for breast cancer research","volume":"13","author":"Holliday","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130913_bb0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/jca.17648","article-title":"Role of tumor microenvironment in tumorigenesis","volume":"8","author":"Wang","year":"2017","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbagen.2026.130913_bb0075","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bbagen.2026.130913_bb0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","article-title":"Extracellular ATP and P2 purinergic signalling in the tumour microenvironment","volume":"18","author":"Di Virgilio","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0085","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbadis.2004.11.001","article-title":"Enzymes that hydrolyze adenine nucleotides in platelets from breast cancer patients","volume":"1740","author":"do Carmo Ara\u00fajo","year":"2005","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbagen.2026.130913_bb0095","doi-asserted-by":"crossref","DOI":"10.1023\/A:1020950420196","article-title":"Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells","author":"Yang","year":"2002","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130913_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01806500","article-title":"Activities of adenosine deaminase, 5\u2032-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues","volume":"37","author":"Canbolat","year":"1996","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130913_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajcp\/82.2.173","article-title":"Identity of the neoplastic alkaline phosphatase as revealed with monoclonal antibodies to the placental form of the enzyme","volume":"82","author":"Loose","year":"1984","journal-title":"Am. J. Clin. Pathol."},{"issue":"18","key":"10.1016\/j.bbagen.2026.130913_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810096","article-title":"Hydrogen peroxide generation as an underlying response to high extracellular inorganic phosphate (Pi) in breast cancer cells","volume":"22","author":"Lacerda-Abreu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3\u20134","key":"10.1016\/j.bbagen.2026.130913_bb0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000430499","article-title":"Role of the tumor microenvironment in breast cancer","volume":"82","author":"Soysal","year":"2015","journal-title":"Pathobiology"},{"key":"10.1016\/j.bbagen.2026.130913_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.868813","article-title":"Mapping breast cancer microenvironment through single-cell omics","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130913_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00280-020-04222-w","article-title":"Tumor microenvironment promotes breast cancer chemoresistance","volume":"87","author":"Mehraj","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol. Rev."},{"issue":"1\u20133","key":"10.1016\/j.bbagen.2026.130913_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-1838(00)00114-4","article-title":"Hyde: the dual role of extracellular ATP","volume":"81","author":"Di Virgilio","year":"2000","journal-title":"J. Auton. Nerv. Syst."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130913_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002599","article-title":"Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase","volume":"3","author":"Pellegatti","year":"2008","journal-title":"PLoS One"},{"issue":"39","key":"10.1016\/j.bbagen.2026.130913_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.1160583","article-title":"Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels","volume":"1","author":"Schenk","year":"2008","journal-title":"Sci. Signal."},{"issue":"3 Pt 1","key":"10.1016\/j.bbagen.2026.130913_bb0150","first-page":"606","article-title":"Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides","volume":"265","author":"Dubyak","year":"1993","journal-title":"Am. J. Phys."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0155","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2012.0101","article-title":"Detecting adenosine triphosphate in the pericellular space","volume":"3","author":"Falzoni","year":"2013","journal-title":"Interfa. Focus"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130913_bb0160","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(93)81397-I","article-title":"Cloning and functional expression of a brain G-protein-coupled ATP receptor","volume":"324","author":"Webb","year":"1993","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130913_bb0165","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbagen.2026.130913_bb0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/B978-0-12-385526-8.00013-8","article-title":"P2Y receptors in health and disease","volume":"61","author":"Erlinge","year":"2011","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130913_bb0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/9780470032244.ch6","article-title":"Agonists and antagonists for P2 receptors","volume":"276","author":"Jacobson","year":"2006","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.bbagen.2026.130913_bb0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol. Rev."},{"issue":"14","key":"10.1016\/j.bbagen.2026.130913_bb0185","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.micinf.2012.07.006","article-title":"P2 receptors and immunity","volume":"14","author":"Rayah","year":"2012","journal-title":"Microbes Infect."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130913_bb0190","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.4049\/jimmunol.143.6.1955","article-title":"Responses of mouse lymphocytes to extracellular adenosine 5\u2032-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP","volume":"143","author":"Di Virgilio","year":"1989","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130913_bb0195","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.4049\/jimmunol.163.4.1958","article-title":"Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation","volume":"163","author":"Mutini","year":"1999","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130913_bb0200","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"issue":"6002","key":"10.1016\/j.bbagen.2026.130913_bb0205","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.1195491","article-title":"Intravascular danger signals guide neutrophils to sites of sterile inflammation","volume":"330","author":"McDonald","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri2938","article-title":"Immune cell regulation by autocrine purinergic signalling","volume":"11","author":"Junger","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130913_bb0215","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission","volume":"87","author":"Burnstock","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbagen.2026.130913_bb0220","article-title":"Ecto-nucleotidases, molecular properties and functional impact","volume":"537","author":"Zimmermann","year":"2007","journal-title":"An. Real Acad. Nac. Farm. Inst. Espana"},{"issue":"4\u20135","key":"10.1016\/j.bbagen.2026.130913_bb0225","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neuint.2007.09.004","article-title":"ATP and acetylcholine, equal brethren","volume":"52","author":"Zimmermann","year":"2008","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/pr.58.1.5","article-title":"Pathophysiology and therapeutic potential of purinergic signaling","volume":"58","author":"Burnstock","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbagen.2026.130913_bb0235","article-title":"Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity","volume":"1\u20137","author":"Hesse","year":"2021","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0240","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/pharmrev.121.000528","article-title":"ATP and adenosine metabolism in cancer: exploitation for therapeutic gain","volume":"74","author":"Yegutkin","year":"2022","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130913_bb0245","doi-asserted-by":"crossref","DOI":"10.1080\/14728222.2019.1559829","article-title":"CD73 as a potential opportunity for cancer immunotherapy","volume":"23","author":"Ghalamfarsa","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"issue":"9","key":"10.1016\/j.bbagen.2026.130913_bb0250","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/cbin.12202","article-title":"Comparative characterisation of an ecto-5\u2032-nucleotidase (CD73) in non-tumoral MCF10-A breast cells and triple-negative MDA-MB-231 breast cancer cells","volume":"48","author":"Rocha-Vieira","year":"2024","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbagen.2026.130913_bb0255","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-385526-8.00010-2","article-title":"Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity","volume":"61","author":"Deaglio","year":"2011","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130913_bb0260","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/onc.2012.269","article-title":"ENTPD1\/CD39 is a promising therapeutic target in oncology","volume":"32","author":"Bastid","year":"2013","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0265","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/2326-6066.CIR-14-0018","article-title":"Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity","volume":"3","author":"Bastid","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0270","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1568009622666220928140702","article-title":"Inorganic phosphate (pi) in the breast cancer microenvironment: production, transport and signal transduction as potential targets for anticancer strategies","volume":"23","author":"Lacerda-Abreu","year":"2023","journal-title":"Curr. Cancer Drug Targets"},{"issue":"12","key":"10.1016\/j.bbagen.2026.130913_bb0275","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41577-020-0376-4","article-title":"Targeting CD39 in cancer","volume":"20","author":"Moesta","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/BJ20111263","article-title":"The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism","volume":"441","author":"Garavaglia","year":"2012","journal-title":"Biochem. J."},{"issue":"Pt 2","key":"10.1016\/j.bbagen.2026.130913_bb0285","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2850345","article-title":"5\u2019-Nucleotidase: molecular structure and functional aspects","volume":"285","author":"Zimmermann","year":"1992","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130913_bb0290","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-1119(93)90635-G","article-title":"Murine ecto-5\u2032-nucleotidase (CD73): cDNA cloning and tissue distribution","volume":"133","author":"Resta","year":"1993","journal-title":"Gene"},{"issue":"1\u20136","key":"10.1016\/j.bbagen.2026.130913_bb0295","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1699-0463.1996.tb00697.x","article-title":"No correlation between CD73 expression and ecto-5\u2032-nucleotidase activity on blood mononuclear cells in vitro: evidence of CD73 (ecto-5\u2032-nucleotidase) on blood mononuclear cells with distinct antigenic properties","volume":"104","author":"Christensen","year":"1996","journal-title":"APMIS"},{"issue":"18","key":"10.1016\/j.bbagen.2026.130913_bb0300","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1021\/bi00521a014","article-title":"5\u2019-Nucleotidase from rat heart","volume":"20","author":"Naito","year":"1981","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0305","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1042\/bj2450805","article-title":"Purification, characterization and cellular localization of 5\u2032-nucleotidase from Torpedo electric organ","volume":"245","author":"Grondal","year":"1987","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep41233","article-title":"Interstitial inorganic phosphate as a tumor microenvironment marker for tumor progression","volume":"7","author":"Bobko","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2026.130913_bb0315","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11302-007-9090-y","article-title":"A case of serendipity","volume":"4","author":"Forrester","year":"2008","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bbagen.2026.130913_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh1261","article-title":"Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression","author":"Mao","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbagen.2026.130913_bb0325","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2174\/156802611795347564","article-title":"The role of extracellular adenosine in chemical neurotransmission in the hippocampus and basal ganglia: pharmacological and clinical aspects","volume":"11","author":"Sperl\u00e1gh","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbagen.2026.130913_bb0330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2009.09.021","article-title":"Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis","volume":"291","author":"Buxton","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagen.2026.130913_bb0335","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jcp.1041140305","article-title":"Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle","volume":"114","author":"Rapaport","year":"1983","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130913_bb0340","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","article-title":"The future of cancer treatment: immunomodulation, CARs and combination immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.bbagen.2026.130913_bb0345","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.3390\/cancers14225663","article-title":"Identification of CD73 as a novel biomarker encompassing the tumor microenvironment, prognosis, and therapeutic responses in various cancers","volume":"14","author":"Tang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130913_bb0350","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1158\/1078-0432.CCR-0811-03","article-title":"Role of estrogen receptor in the regulation of ecto-5\u2032-nucleotidase and adenosine in breast cancer","volume":"10","author":"Spychala","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0355","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11302-021-09824-4","article-title":"Is the regulation by miRNAs of NTPDase1 and ecto-5\u2032-nucleotidase genes involved with the different profiles of breast cancer subtypes?","volume":"18","author":"da Silva","year":"2022","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bbagen.2026.130913_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152256","article-title":"Characterization of Mg-independent and Mg-dependent ecto-ATPase activities in luminal a breast cancer MCF-7 cells","volume":"777","author":"Lacerda-Abreu","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130913_bb0365","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202300242","article-title":"Suppressing the hypoxia-adenosinergic axis by a tailored nanoreactor for enhanced photothermal immunotherapy","volume":"4","author":"Gu","year":"2024","journal-title":"Small Sci."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130913_bb0370","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.241463","article-title":"Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia","volume":"133","author":"Losenkova","year":"2020","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2026.130913_bb0375","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10585-007-9081-y","article-title":"RNA interference of ecto-5\u2032-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion","volume":"24","author":"Zhi","year":"2007","journal-title":"Clin. Exp. Metastasis"},{"issue":"11","key":"10.1016\/j.bbagen.2026.130913_bb0380","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.2005.11.890","article-title":"Critical update and emerging trends in epidermal growth factor receptor targeting in cancer","volume":"23","author":"Baselga","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.bbagen.2026.130913_bb0385","first-page":"8221","article-title":"Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation","volume":"63","author":"Hofmann","year":"2003","journal-title":"Cancer Res."},{"issue":"Pt 1","key":"10.1016\/j.bbagen.2026.130913_bb0390","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/bj2820181","article-title":"Modulation of 5\u2032-nucleotidase activity in plasma membranes and intact cells by the extracellular matrix proteins laminin and fibronectin","volume":"282","author":"Olmo","year":"1992","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0395","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4161\/cbt.6.3.3762","article-title":"Overexpression of Ecto-5\u2032-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix","volume":"6","author":"Zhou","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130913_bb0400","article-title":"Enhancing chemotherapy efficacy: investigating the synergistic impact of paclitaxel and CD73 gene suppression on breast cancer cell proliferation and migration","volume":"16","author":"Hamidnia","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.bbagen.2026.130913_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1366197","article-title":"Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model","volume":"15","author":"Mediratta","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbagen.2026.130913_bb0410","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PAI.0b013e3182311d82","article-title":"CD73 expression as a potential marker of good prognosis in breast carcinoma","volume":"20","author":"Supernat","year":"2012","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0415","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/ajco.13450","article-title":"Expression of CD73 is associated with tumor progression and intratumoral inflammation in breast cancer","volume":"18","author":"Choi","year":"2022","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0420","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2152636","article-title":"A role for EMT in CD73 regulation in breast cancer","volume":"11","author":"Hasmim","year":"2022","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.bbagen.2026.130913_bb0425","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1349-7006.2010.01733.x","article-title":"RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells","volume":"101","author":"Zhi","year":"2010","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130913_bb0430","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1073\/pnas.0908801107","article-title":"Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis","volume":"107","author":"Stagg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130913_bb0435","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00432-007-0292-z","article-title":"Ecto-5\u2032-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells","volume":"134","author":"Wang","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130913_bb0440","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.21873\/anticanres.17187","article-title":"Stromal CD73 expression in breast cancer: subtype-specific expression and its prognostic significance","volume":"44","author":"Tanaka","year":"2024","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130913_bb0445","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/annonc\/mdx730","article-title":"Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial","volume":"29","author":"Buisseret","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbagen.2026.130913_bb0450","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1186\/s12967-023-04714-2","article-title":"Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Transl. Med."},{"issue":"23","key":"10.1016\/j.bbagen.2026.130913_bb0455","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.3390\/cancers13235878","article-title":"CD73-mediated immunosuppression is linked to a specific fibroblast population that paves the way for new therapy in breast cancer","volume":"13","author":"Magagna","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.bbagen.2026.130913_bb0460","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1158\/2326-6066.CIR-19-0923","article-title":"An IL6-adenosine positive feedback loop between CD73+ \u03b3\u03b4Tregs and CAFs promotes tumor progression in human breast cancer","volume":"8","author":"Hu","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbagen.2026.130913_bb0465","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40425-016-0154-9","article-title":"Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor-associated macrophages\u2014a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape","volume":"4","author":"Montalb\u00e1n Del Barrio","year":"2016","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.bbagen.2026.130913_bb0470","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007279","article-title":"First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the neo-CheckRay trial","volume":"11","author":"De Caluwe","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.bbagen.2026.130913_bb0475","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005802","article-title":"Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer","volume":"10","author":"Miller","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0480","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/neuonc\/noae169","article-title":"ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in human epidermal growth factor receptor 2-positive breast cancer","volume":"27","author":"Santos","year":"2025","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.bbagen.2026.130913_bb0485","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1007\/s00018-020-03742-1","article-title":"Enzymology of extracellular NAD metabolism","volume":"78","author":"Gasparrini","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130913_bb0490","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.immuni.2024.02.019","article-title":"New frontiers in the cGAS-STING intracellular DNA-sensing pathway","volume":"57","author":"Dvorkin","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0495","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.179.1.186","article-title":"NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo","volume":"179","author":"Adriouch","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130913_bb0500","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tips.2018.02.001","article-title":"The pharmacology of CD38\/NADase: an emerging target in cancer and diseases of aging","volume":"39","author":"Chini","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbagen.2026.130913_bb0505","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1038\/s41418-020-00624-8","article-title":"Crosstalk between cGAS\u2013STING signaling and cell death","volume":"27","author":"Murthy","year":"2020","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130913_bb0510","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/2159-8290.CD-20-0387","article-title":"Metastasis and immune evasion from extracellular cGAMP hydrolysis","volume":"11","author":"Li","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbagen.2026.130913_bb0515","first-page":"2602","article-title":"The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine","volume":"53","author":"Blay","year":"1997","journal-title":"Cancer Res."},{"issue":"4\u20135","key":"10.1016\/j.bbagen.2026.130913_bb0520","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002100000309","article-title":"Extracellular metabolism of ATP and other nucleotides","volume":"362","author":"Zimmermann","year":"2000","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0525","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1748-1716.1991.tb09133.x","article-title":"Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism","volume":"142","author":"Ballar\u00edn","year":"1991","journal-title":"Acta Physiol. Scand."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130913_bb0530","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.3390\/ijms19123837","article-title":"Targeting adenosine receptor signaling in cancer immunotherapy","volume":"19","author":"Sek","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130913_bb0535","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tips.2016.02.006","article-title":"Adenosine as a multi-signalling Guardian angel in human diseases: when, where and how does it exert its protective effects?","volume":"37","author":"Borea","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0540","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11033-024-09382-z","article-title":"Adenosine receptors in breast cancer","volume":"51","author":"Mahdizadeh","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbagen.2026.130913_bb0545","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11302-013-9372-5","article-title":"Purinergic signalling and cancer","volume":"9","author":"Burnstock","year":"2013","journal-title":"Purinergic Signal"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130913_bb0550","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bjp.0706180","article-title":"Human breast cancer cell line MDA-MB-231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal","volume":"145","author":"Panjehpour","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.bbagen.2026.130913_bb0555","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1158\/0008-5472.CAN-16-0544","article-title":"Adenosine 2B receptor expression on cancer cells promotes metastasis","volume":"76","author":"Mittal","year":"2016","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.bbagen.2026.130913_bb0560","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1073\/pnas.1222085110","article-title":"Identification of a pharmacologically tractable Fra-1\/ADORA2B axis promoting breast cancer metastasis","volume":"110","author":"Desmet","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.bbagen.2026.130913_bb0565","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2008-02-136325","article-title":"Adenosine receptors in regulation of dendritic cell differentiation and function","volume":"112","author":"Novitskiy","year":"2008","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.bbagen.2026.130913_bb0570","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1158\/1078-0432.CCR-08-0229","article-title":"Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia","volume":"14","author":"Sitkovsky","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"36","key":"10.1016\/j.bbagen.2026.130913_bb0575","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1073\/pnas.1308209110","article-title":"Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors","volume":"110","author":"Beavis","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.bbagen.2026.130913_bb0580","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","article-title":"Turning cold tumors hot: from molecular mechanisms to clinical applications","volume":"43","author":"Zhang","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbagen.2026.130913_bb0585","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.omto.2020.09.010","article-title":"Oncolytic reovirus-mediated recruitment of early innate immune responses reverses immunotherapy resistance in prostate tumors","volume":"20","author":"Annels","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0590","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12951-024-02525-1","article-title":"A combination of a TLR7\/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune","volume":"22","author":"Jiang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbagen.2026.130913_bb0595","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fphar.2018.00627","article-title":"Who is who in adenosine transport","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130913_bb0600","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mehy.2013.10.028","article-title":"Measurement of blood phosphorus: a quick and inexpensive method for detection of the existence of cancer in the body. Too good to be true, or forgotten knowledge of the past?","volume":"82","author":"Papaloucas","year":"2014","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130913_bb0605","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbcan.2018.05.001","article-title":"Inorganic phosphate transporters in cancer: functions, molecular mechanisms and possible clinical applications","volume":"1870","author":"Lacerda-Abreu","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130913_bb0610","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200802-306OC","article-title":"High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling","volume":"179","author":"Jin","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130913_bb0615","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1461-0248.2000.00185.x","article-title":"Biological stoichiometry from genes to ecosystems","volume":"3","author":"Elser","year":"2000","journal-title":"Ecol. Lett."},{"issue":"9","key":"10.1016\/j.bbagen.2026.130913_bb0620","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/mc.22153","article-title":"Inorganic phosphate induces cancer cell-mediated angiogenesis dependent on forkhead box protein C2 (FOXC2) regulated osteopontin expression","volume":"54","author":"Lin","year":"2015","journal-title":"Mol. Carcinog."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T09:32:54Z","timestamp":1770715974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0304416526000139"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130913","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ectonucleotidases: Possible roles in the tumor microenvironment and influence on tumor progression in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130913"}}